Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
We provide 1 form of Nilotinib
Nilotinib
641571-10-0
|
529.516
|
5.844
Nilotinib is a kinase inhibitor used for the chronic phase treatment of Chronic Myeloid Leukemia (CML) that is Philadelphia chromosome positive and for the treatment of CML that is resistant to therapy containing imatinib.
AMN-107 | Tasigna | [Bodipy-FL]-Nilotinib | nilotinib
Nilotinib is a kinase inhibitor used for the chronic phase treatment of Chronic Myeloid Leukemia (CML) that is Philadelphia chromosome positive and for the treatment of CML that is resistant to therapy containing imatinib.
AMN-107 | Tasigna | [Bodipy-FL]-Nilotinib | nilotinib
$19/5 mg
(EBC)
1
We provide 3 compounds for Nilotinib
Nilotinib impurity C CRS; Nilotinib Related compound C
3-amino-4-methylbenzoic acid
-
2458-12-0
151.063
1.427
$19/5 mg
(EBC)
1
Nilotinib impurity B CRS
methyl 3-amino-4-methylbenzoate
-
18595-18-1
165.079
1.843
$19/5 mg
(EBC)
1
Nilotinib impurity A CRS; Nilotinib Related Compound A
3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline
3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline
641571-11-1
241.212
2.561
$19/5 mg
(EBC)
1